Gatifloxacin 4mg/ml Infusion
| Product/Composition:- | Gatifloxacin 4mg/ml Infusion |
|---|---|
| Strength:- | 100 ml |
| Form:- | Infusion |
| Production Capacity | 1 Million Infusion/Month |
| Therapeutic use:- | Fluid Therapy |
| Package Insert/Leaflet: | Available upon request |
Description
TEQUIN (gatifloxacin removed from us market – may 2006) Injection for Intravenous Administration TEQUIN (gatifloxacin removed from us market – may 2006) Injection is available in 40-mL (400-mg) single-use vials as a sterile, preservative-free aqueous solution of gatifloxacin with pH ranging from 3.5 to 5.5. TEQUIN (gatifloxacin in 5% dextrose) Injection is also available in ready-to-use 100-mL (200-mg) and 200-mL (400-mg) flexible bags as a sterile, preservative-free aqueous solution of gatifloxacin with pH ranging from 3.5 to 5.5. The appearance of the intravenous solution may range from light yellow to greenish-yellow in color.
The color does not affect nor is it indicative of product stability. The intravenous formulation contains dextrose, anhydrous, USP or dextrose, monohydrate, USP and Water for Injection, USP, and may contain hydrochloric acid and/or sodium hydroxide for pH adjustment.